Opioid Antagonist Product Supplier

This subcontract agreement establishes a partnership for the supply of intranasal and intramuscular opioid antagonist medications to support prime contractors working on projects for the North Carolina Department of Mental Health. The scope of work encompasses the entire production cycle, including the manufacture, formulation, compounding, and labeling of the medications. Specific product requirements include the provision of intramuscular vials and two-dose intranasal packages with a maximum dosage of 4mg. To ensure safety and efficacy, all products must utilize FDA-compliant packaging and maintain a minimum shelf life of 18 months. The supplier is responsible for the final delivery of these medications to the designated prime contractor or distribution point. This procurement is managed under the North Carolina Department of Health and Human Services with a response deadline of October 23, 2026.